PF-05231023
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Pharmacological administration of FGF21 analogues has shown robust body weight reduction and lipid profile improvement in both…
In 2016, four studies were published that provided crucial new information on the endocrine actions of the hormone fibroblast…
To assess the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐05231023, a long‐acting fibroblast growth factor…
AIMS
The aim of the present study was to evaluate the pharmacokinetics/pharmacodynamics (PK/PD), safety and tolerability of…
Pharmacological administration of fibroblast growth factor 21 (FGF21) improves metabolic profile in preclinical species and…
PF-05231023, a long-acting fibroblast growth factor 21 (FGF21) analog, was generated by covalently conjugating two engineered…